SciBase Q2 net loss widens 26.1% to SEK 28,893 million; net sales more than doubled 74% to SEK 15.31 million

Reuters2026/08/19 06:03

By: Reuters

SciBase reported Q2 net sales of SEK 15.31 million, up 74% year over year.
Net loss widened to SEK 28.89 million; loss per share was SEK 2.83.
Gross margin fell 13.6 percentage points to 52.6% due to FX, Castle study deliveries, higher gold prices, capacity investments.
Operating cash flow deepened to SEK 33.1 million; electrode unit sales more than doubled to 40,144.
Post-quarter, filed an FDA 510(k) to expand Nevisense’s US indication to non-melanoma skin cancer assessment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SciBase Holding AB published the original content used to generate this news brief via Cision (Ref. ID: 202608190200BITN____UKPR__SV_20260818-BIT-9199-0) on August 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

SciBase Q2 net loss widens 26.1% to SEK 28,893 million; net sales more than doubled 74% to SEK 15.31 million

You may also like

Trending news

Crypto prices